Zobrazeno 1 - 8
of 8
pro vyhledávání: '"G V Shelkova"'
Publikováno v:
Системные гипертензии, Vol 15, Iss 4, Pp 34-38 (2018)
Objective. To study the efficacy and safety of radiofrequency renal denervation with mono-electrode and multi-electrode devices in patients with uncontrolled arterial hypertension during follow-up period. Materials and methods. The study included 42
Externí odkaz:
https://doaj.org/article/5f45dfcec63f49a3a89fbe7d5f8539ec
Publikováno v:
Системные гипертензии, Vol 11, Iss 4, Pp 21-26 (2014)
Despite the availability of modern medicines for treating the majority of cardiovascular diseases, the existence of such severe diseases as refractory arterial hypertension and pulmonary hypertension, has brought us to the development of the pathogen
Externí odkaz:
https://doaj.org/article/72294615207540d5a9ebfa13a7299ed5
Publikováno v:
Системные гипертензии, Vol 12, Iss 1, Pp 8-9 (2015)
Externí odkaz:
https://doaj.org/article/f25a59f36bd44ff6bf23c9178a267ecb
Autor:
Victor Fomin, Elena V. Oshchepkova, G V Shelkova, Aleksandr Yu. Litvin, Irina Chazova, E M Elfimova, Nikolai M. Danilov, Oksana A. Kisliak, A V Aksenova, Chikhladze Nm, Olga A. Sivakova, N V Blinova
Publikováno v:
Терапевтический архив, Vol 93, Iss 9, Pp 1018-1029 (2021)
The diagnosis of resistant arterial hypertension allows us to single out a separate group of patients in whom it is necessary to use special diagnostic methods and approaches to treatment. Elimination of reversible factors leading to the development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0343d68be0574327a5370da4c31d98c
https://pubmed.ncbi.nlm.nih.gov/36286860
https://pubmed.ncbi.nlm.nih.gov/36286860
Publikováno v:
Системные гипертензии, Vol 15, Iss 4, Pp 34-38 (2018)
Objective. To study the efficacy and safety of radiofrequency renal denervation with mono-electrode and multi-electrode devices in patients with uncontrolled arterial hypertension during follow-up period. Materials and methods. The study included 42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06175206b43649053154fe71ee51d900
https://doi.org/10.26442/2075082x.2018.4.000043
https://doi.org/10.26442/2075082x.2018.4.000043
Publikováno v:
Системные гипертензии, Vol 11, Iss 4, Pp 21-26 (2014)
Despite the availability of modern medicines for treating the majority of cardiovascular diseases, the existence of such severe diseases as refractory arterial hypertension and pulmonary hypertension, has brought us to the development of the pathogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::592db15b8b5998b0804ba6f7368899cd
https://doi.org/10.26442/sg29040
https://doi.org/10.26442/sg29040
Publikováno v:
Kardiologicheskii vestnik. 13:22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d2ba4f9bd1ad78883ded0ecf27cb7a0
https://doi.org/10.17116/cardiobulletin201813222
https://doi.org/10.17116/cardiobulletin201813222
Publikováno v:
Системные гипертензии, Vol 12, Iss 1, Pp 8-9 (2015)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285ada376ed96fe2073e4bb2b6758722
https://doi.org/10.26442/2075-082x_12.1.8-9
https://doi.org/10.26442/2075-082x_12.1.8-9